Skip to content

Clinical trials

Diabetic Retinopathy trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Country / region: China Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20112
20131
20141
20153
20161
20172
20188
20196
20204
20216
20225
20234
20244
20258
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status24
Completed21
Not yet recruiting7
Recruiting7
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zhongshan Ophthalmic Center, Sun Yat-sen University8
Sun Yat-sen University7
Ruijin Hospital3
Bayer2
Chengdu University of Traditional Chinese Medicine2
Shanghai Eye Disease Prevention and Treatment Center2
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine2
Shanghai Jiao Tong University School of Medicine2
Third Affiliated Hospital, Sun Yat-Sen University2
Zhongnan Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy60
Diabetes Mellitus9
Diabetes Mellitus, Type 26
Retinal Diseases5
Retinal Vein Occlusion5
Glaucoma4
Macular Degeneration4
Macular Edema4
Glaucoma, Neovascular3
Choroidal Neovascularization2

Trials

Showing 26 to 50 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.